OBIO® News

OBIO® Press Releases

Industry News

Featured
LSO launches new report calling for urgent actionto bridge critical funding gap threatening Ontario's innovation leadership
Read More →
Flosonics’ FloPatch expands to East Coast
Read More →
OBIO® companies recognized in Betakit's new report
Read More →
Atorvia shines in the latest edition of BIOTECanada's INSIGHTS magazine
Read More →
OBIO® x CATTI's biomanufacturing initiative featured in BIOTECanada's INSIGHTS magazine
Read More →
Spiderwort Biotech receives Health Canada Investigational Testing Authorization for CelluJuve®
Read More →
Hyivy Health spotlighted in this feature by the Canadian Medical Association
Read More →
Stem Cell Network announces $33M to advance regenerative medicine research and clinical trials
Read More →
OBIO® supports A4i to expand Canadian presence through new partnership with Waypoint Centre for Mental Health Care
Read More →
ToeFX Featured on Global News Health Matters Segment
Read More →
Satellos Announces Promising Phase 1b Trial Results of SAT-3247 in Adults with Duchenne Muscular Dystrophy
Read More →
ProteinQure Secures Series A to Advance First AI-Designed Peptide Therapeutic into Clinical Trials
Read More →
Neuropeutics Receives the Inaugural AbbVie Biotech Innovators Award
Read More →
JN Nova Pharma Secures Health Canada Approval for Phase I Trial of its Long COVID Therapy
Read More →
The Time is Right to Invest in Canadian Biotechnology and Stop Subsidizing Foreign Biotechnology Companies
Read More →
Swift Medical Wins MedTech Breakthrough Home Healthcare Innovation Award
Read More →
Novartis Canada Extends Health Equity Initiative
Read More →
Foqus Technologies’ DeepFoqus-Accelerate Receives FDA Clearance
Read More →
Cosm Medical Secures First Tranche of Seed Extension
Read More →
Why the GTA is Still Facing a Monumental Shortage of Lab Space
Read More →
Ontario's Wet Lab Funding Shortage Could Drive Innovation Exodus
Read More →